Heestand GM - Search Results

1

Approach to patients with pancreatic cancer without detectable metastases.

Heestand GM, Murphy JD, Lowy AM. Heestand GM, et al. J Clin Oncol. 2015 Jun 1;33(16):1770-8. doi: 10.1200/JCO.2014.59.7930. Epub 2015 Apr 27. J Clin Oncol. 2015. PMID: 25918279 Review.

2

Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer.

Simpson DR, Martínez ME, Gupta S, Hattangadi-Gluth J, Mell LK, Heestand G, Fanta P, Ramamoorthy S, Le QT, Murphy JD. Simpson DR, et al. J Natl Cancer Inst. 2013 Dec 4;105(23):1814-20. doi: 10.1093/jnci/djt318. Epub 2013 Nov 14. J Natl Cancer Inst. 2013. PMID: 24231453 Free PMC article.

3

FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors.

Shi E, Chmielecki J, Tang CM, Wang K, Heinrich MC, Kang G, Corless CL, Hong D, Fero KE, Murphy JD, Fanta PT, Ali SM, De Siena M, Burgoyne AM, Movva S, Madlensky L, Heestand GM, Trent JC, Kurzrock R, Morosini D, Ross JS, Harismendy O, Sicklick JK. Shi E, et al. Among authors: heestand gm. J Transl Med. 2016 Dec 14;14(1):339. doi: 10.1186/s12967-016-1075-6. J Transl Med. 2016. PMID: 27974047 Free PMC article.

4

Molecular landscape of pancreatic cancer: implications for current clinical trials.

Heestand GM, Kurzrock R. Heestand GM, et al. Oncotarget. 2015 Mar 10;6(7):4553-61. doi: 10.18632/oncotarget.2972. Oncotarget. 2015. PMID: 25714017 Free PMC article. Review.

5

A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3.

Shultz DB, Pai J, Chiu W, Ng K, Hellendag MG, Heestand G, Chang DT, Tu D, Moore MJ, Parulekar WR, Koong AC. Shultz DB, et al. PLoS One. 2016 Jan 25;11(1):e0147995. doi: 10.1371/journal.pone.0147995. eCollection 2016. PLoS One. 2016. PMID: 26808546 Free PMC article. Clinical Trial.

6

Survival after neoadjuvant approaches to gastroesophageal junction cancer.

Xiang M, Chang DT, Heestand GM, Pollom EL. Xiang M, et al. Among authors: heestand gm. Gastric Cancer. 2020 Jan;23(1):175-183. doi: 10.1007/s10120-019-00980-6. Epub 2019 Jun 22. Gastric Cancer. 2020. PMID: 31230228

7

Neoadjuvant treatment strategies for resectable pancreas cancer: A propensity-matched analysis of the National Cancer Database.

Xiang M, Heestand GM, Chang DT, Pollom EL. Xiang M, et al. Among authors: heestand gm. Radiother Oncol. 2020 Feb;143:101-107. doi: 10.1016/j.radonc.2020.01.007. Epub 2020 Feb 7. Radiother Oncol. 2020. PMID: 32044168

8

Topoisomerase expression and amplification in solid tumours: Analysis of 24,262 patients.

Heestand GM, Schwaederle M, Gatalica Z, Arguello D, Kurzrock R. Heestand GM, et al. Eur J Cancer. 2017 Sep;83:80-87. doi: 10.1016/j.ejca.2017.06.019. Epub 2017 Jul 17. Eur J Cancer. 2017. PMID: 28728050 Free PMC article.

9

The Mutational Landscape of Gastrointestinal Malignancies as Reflected by Circulating Tumor DNA.

Riviere P, Fanta PT, Ikeda S, Baumgartner J, Heestand GM, Kurzrock R. Riviere P, et al. Among authors: heestand gm. Mol Cancer Ther. 2018 Jan;17(1):297-305. doi: 10.1158/1535-7163.MCT-17-0360. Epub 2017 Nov 13. Mol Cancer Ther. 2018. PMID: 29133621 Free PMC article.

10

Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma.

Ikeda S, Tsigelny IF, Skjevik ÅA, Kono Y, Mendler M, Kuo A, Sicklick JK, Heestand G, Banks KC, Talasaz A, Lanman RB, Lippman S, Kurzrock R. Ikeda S, et al. Oncologist. 2018 May;23(5):586-593. doi: 10.1634/theoncologist.2017-0479. Epub 2018 Feb 27. Oncologist. 2018. PMID: 29487225 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters